Document Details
Form
Filing Date
Jun 20, 2018
Document Date
Jun 18, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Syndax Pharmaceuticals, Inc.
Issuer
Syndax Pharmaceuticals Inc
Filer
BIOTECHNOLOGY VALUE FUND II LP